Ono Venture Investment (investor - Corporate Investor)

See something wrong or missing? Let us know
Offices:San Francisco

Ono Venture Investment - OVI is the corporate venture capital arm of Ono Pharmaceutical Co in the USA

Average round investment:32M USD
Average number per year:1.0
Distribution: 2025 (1)
Portfolio companies: United Kingdom Alchemab
Mostly invests in: United Kingdom United Kingdom (1) Biotech (1)

1 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Top